Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Beckman coulter has identified the following drugs as potential sources of interference: metamizole (dipyrone) - analgesic/antispasmodic/antipyretic (note: no longer approved for sale in certain geographies including the us and canada) may generate false low cholesterol enzymatic creatinine hdl cholesterol lactate triglycerides and uric acid results. sulfasalazine - anti-inflammatory may generate false high salicylate results. sulfapyridine - sulfonamide antibiotic may generate false low salicylate results.